Initiative, PBC

Dedicated to the study and eradication of Coronaviridae

/ Detection

We are developing a point of care antigen test that quickly and accurately detects SARS-CoV-2

Lateral Flow Assay for Detection of 2019-nCov antigen
Our Lateral Flow Assay point of care tests in development provide fast, accurate identification of whole virus and virus particles, beginning with SARS-CoV-2. Unlike serological tests, which suffer from delay and low sensitivity and specificity, our test detects the virus directly. The test is low cost, shelf stable, and works on saliva samples.